Antacids Market

Antacids Market Size by Drug Class (Proton Pump Inhibitors, Acid Neutralizers, Anti-H.Pyrolic Drugs, H2 Antagonist, Pro-Motility Agents, Prostaglandin Analogous, and Others), Formulation Type (Tablet, Powder, Capsule, Liquid and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2023 to 2032

Base Year: 2022 Historical Data: 2019-21
  • Report ID: TBI-13981
  • Published Date: Jan, 2024
  • Pages: 236
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global antacids market was valued at USD 7 billion in 2022 and grew at a CAGR of 4% from 2023 to 2032. The market is expected to reach USD 10.36 billion by 2032. The increasing prevalence of acidity, heartburn and other gastrointestinal problems will drive the growth of the global antacids market.

Market Introduction:

Antacids are medications designed to neutralize excessive stomach acid. They offer relief from symptoms like heartburn, indigestion, and acid reflux. Antacids are basic and raise the pH level of stomach contents, mitigating acidity and addressing discomfort associated with elevated stomach acid levels, which are acidic. Antacids are an accessible option as they can be obtained without a prescription, allowing individuals to self-treat mild symptoms conveniently. They are widely available over the counter in various forms, including tablets, liquids, and chewable tablets. They offer quick and symptomatic relief. The benefits of antacids include their rapid efficacy, over-the-counter availability, and diverse formulations catering to individual preferences. Antacids are readily accessible and effective options for managing short-term symptoms of excess stomach acidity. They are now available in different variants and offer efficacy with taste and flavour.

Antacids Market Size

Get an overview of this study by requesting a free sample

Recent Development
  • The firm is expanding its product line with the fifth flavour option, Wonderbelly Tropical Fruit antacid, to offer consumers an even more delectable way to manage heartburn. The antacid has a Non-GMO Project Verified profile and is made with the brand's distinctive recipe, which uses calcium carbonate to quickly relieve heartburn. It is also Clean Label Project approved. The medicine also helps with sour stomach, upset stomach, and acid reflux to give it a more multifunctional profile. Mango, pineapple, and tropical citrus flavours are said to be present in the Wonderbelly Tropical Fruit antacid, making it more of a delight than a conventional heartburn remedy.

Market Dynamics:


The increasing prevalence of heartburn and acidity – lifestyle and dietary changes are associated with increased consumption of spicy or acidic foods with irregular eating patterns, which contribute to an increasing prevalence of conditions such as heartburn and indigestion. The rise in acid-related issues, including gastroesophageal reflux disease (GERD), can be attributed to factors such as obesity and other modern lifestyle choices. Stress sed,entary lifestyles, and irregular sleep patterns exacerbate digestive problems. The accessibility of antacids over the counter enhances their widespread use for self-treatment. Therefore, the increasing prevalence of indigestion and similar conditions, given the lifestyle changes, will contribute to the global antacid market's growth.


Side-effects associated with antacids antacids can cause constipation and diarrhoea. Prolonged use of magnesium or aluminium-based antacids may disrupt mineral absorption, impacting bone health. Abruptly stopping antacid use can cause "acid rebound," temporarily increasing stomach acid production. Rare Allergic reactions to antacid ingredients include rash, swelling, or difficulty breathing. All these side effects are undesirable and may also lead to antacids assisting in concealing an underlying serious condition for indigestion and heartburn through its temporary relief. However, this can be disastrous in the long run, and therefore, the undesirable side effects associated with antacids will hamper the market's growth.

  • Following the voluntary recall of multiple batches of Digene Gel antacids by drugmaker Abbott India, the Drug Controller General of India (DCGI) issued a warning against using the product. According to the agency, the product under scrutiny, produced at the company's Goa facility, may be dangerous and have unfavourable impacts if consumed. In addition, the government has instructed physicians to inform patients about potential side effects from product intake and to refrain from providing the medication to them. State drug controllers have been instructed to closely monitor the movement, sale, distribution, and inventory of the products as mentioned earlier on the market, collect samples if the product is found there, and take appropriate action.

The growing innovation leading to the introduction of new products the increased innovation and product development focus on enhancing formulations to meet evolving consumer needs. Companies are investing heavily in research to improve the efficacy, duration of action, and flavour profiles of antacids. For instance, the development of fast-acting varieties for immediate relief and formulations with natural or alternative ingredients is opening up new market opportunities for the industry. Continuous research and development efforts contribute to the future growth of the global antacids market.

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the most significant global antacids market, with a 39% market revenue share in 2022.

The significant prevalence of acid-related conditions like GERD and heartburn, given the dietary patterns rich in processed acidic foods, contributes to the region's dominance in the global antacids market. Lifestyle factors such as stress, irregular eating, and obesity contribute to digestive issues, increasing the demand for antacids. Over-the-counter availability improves accessibility to antacids, thereby driving the market’s growth in the region. The ageing population in the region further sustains the demand for antacids, given the increased susceptibility of older individuals to digestive problems.

North America Region Antacids Market Share in 2022 - 39%

Check the geographical analysis of this market by requesting a free sample

Drug Class Segment Analysis

The drug class segment is divided into proton pump inhibitors, acid neutralizers, anti-H.pyrolic drugs, H2 antagonist, pro-motility agents, prostaglandin analogous, and others. The proton pump inhibitors segment dominated the market, with a market share of around 31% in 2022. Proton pump inhibitors are drugs that inhibit the production of stomach acid. It plays a crucial role in managing acid-related conditions. PPIs reduce acid production by blocking the proton pump enzyme. It is commonly prescribed for conditions like gastroesophageal reflux disease (GERD) and peptic ulcers. They offer long-lasting relief from symptoms such as heartburn and regurgitation. They are effective in preventing complications associated with chronic acid-related conditions. PPIs improve the quality of life for individuals managing these conditions, offering sustained symptom relief.

Formulation type Segment Analysis

The formulation type segment is divided into tablet, powder, capsule, liquid and others. The tablet segment dominated the market, with a market share of around 39% in 2022. Tablets are solid pharmaceutical dosage forms widely used for drug delivery. They offer convenient consumption, formulation of accurate dosages and ease of administration. Tablets have advantages over other forms, including portability, longer shelf life, taste masking, and dosing flexibility. The convenience and familiarity of tablets contribute to better patient compliance.

Distributional Channel Segment Analysis

The distribution channel segment is divided into hospital pharmacies, retail pharmacies and online pharmacies. The retail pharmacies segment dominated the market, with a market share of around 46% in 2022. Retail pharmacies include chain drugstores and independent outlets. They are accessible establishments as they provide convenient locations in neighbourhoods. They also offer Quick services with efficient systems for processing and dispensing medications. Extended hours or round-the-clock availability contribute to their popularity. Pharmacist consultations enhance the overall customer experience. The comprehensive range of drugs/medications, convenience and personalized interactions make retail pharmacies the go-to destination for consumers.

Some of the Key Market Players:
  • Abbott Laboratories
  • Alkem Laboratories Ltd.
  • Bayer AG
  • Cipla Ltd.
  • Haleon plc
  • Infirst Healthcare Inc.
  • Pfizer Inc.
  • Prestige Consumer Healthcare Inc.
  • Reckitt Benckiser Group PLC
  • WellSpring Pharmaceutical Corporation

Report Description:

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2022 USD 7 Billion
Market size value in 2032 USD 10.36 Billion
CAGR (2023 to 2032) 4%
Historical data 2019-2021
Base Year 2022
Forecast 2023-2032
Region The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East and Africa. Furthermore, the regions are further analyzed at the country level.
Segments Drug Class, Formulation Type and Distribution Channel

Frequesntly Asked Questions

As per The Brainy Insights, the size of the global antacids market was valued at USD 7 billion in 2022 to USD 10.36 billion by 2032.

Global antacids market is growing at a CAGR of 4% during the forecast period 2023-2032.

The market's growth will be influenced by the increasing prevalence of heartburn and acidity.

Side-effects associated with antacids could hamper the market growth.

Request Table of Content


This study forecasts revenue at global, regional, and country levels from 2019 to 2032. The Brainy Insights has segmented the global antacids market based on below mentioned segments:

Global Antacids Market by Drug Class:

  • Proton Pump Inhibitors
  • Acid Neutralizers
  • Anti-H.Pyrolic Drugs
  • H2 Antagonist
  • Pro-Motility Agents
  • Prostaglandin Analogous
  • Others

Global Antacids Market by Formulation Type:

  • Tablet
  • Powder
  • Capsule
  • Liquid
  • Others

Global Antacids Market by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Antacids Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa


Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:


Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights


Free Customization


Fortune 500 Clients


Free Yearly Update On Purchase Of Multi/Corporate License


Companies Served Till Date